Lisata Therapeutics, Inc. (LSTA) Earnings History
Net Loss32 years of earnings data (1994–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Lisata Therapeutics, Inc. (LSTA) Earnings Overview
As of July 8, 2026, Lisata Therapeutics, Inc. (LSTA) reported trailing twelve-month net income of -$16M, reflecting +20.4% year-over-year growth. The company earned $-1.82 per diluted share over the past four quarters, with a net profit margin of -9756.5%.
Looking at the long-term picture, LSTA's historical earnings data spans multiple years. The company achieved its highest annual net income of $23M in fiscal 2017.
Lisata Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ADCT (-$137M net income, -175.3% margin), IMVT (-$506M net income), TPVG (-$12M net income, 50.6% margin), LSTA has room to improve margins relative to the peer group. Compare LSTA vs ADCT →
LSTA Earnings vs Peers
Earnings metrics vs comparable public companies
LSTA Historical Earnings Data (1994–2025)
31 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$17M | +17.0% | -$18M | $-1.91 | -9756.5% | -10711.2% |
| 2024 | -$20M | +4.1% | -$22M | $-2.40 | -1998.5% | -2240.9% |
| 2023 | -$21M | +61.6% | -$26M | $-2.58 | - | - |
| 2022 | -$54M | -97.4% | -$58M | $-10.47 | - | - |
| 2021 | -$27M | -237.0% | -$29M | $-7.45 | - | - |
| 2020 | -$8M | +59.5% | -$19M | $-7.91 | - | - |
| 2019 | -$20M | -24.3% | -$20M | $-29.20 | - | - |
| 2018 | -$16M | -170.4% | -$17M | $-25.03 | - | - |
| 2017 | $23M | +170.4% | -$28M | $38.43 | - | - |
| 2016 | -$33M | +59.6% | -$31M | $-74.81 | -92.6% | -88.8% |
| 2015 | -$81M | -47.4% | -$52M | $-250.12 | -359.7% | -229.3% |
| 2014 | -$55M | -40.8% | -$58M | $-251.28 | -305.9% | -321.9% |
| 2013 | -$39M | +28.8% | -$37M | $-285.29 | -265.7% | -250.9% |
| 2012 | -$55M | -16.2% | -$30M | $-600.00 | -382.3% | -212.0% |
| 2011 | -$47M | -102.2% | -$34M | $-810.00 | -469.0% | -338.4% |
| 2010 | -$23M | +10.9% | -$19M | $-677.08 | -33.4% | -27.0% |
| 2009 | -$26M | -183.2% | -$26M | $-3660.00 | -226.3% | -223.7% |
| 2008 | -$9M | +11.5% | -$9M | $-2295.00 | -11062.9% | -11052.6% |
| 2007 | -$10M | -72.6% | -$10M | $-4770.00 | -4508.9% | -4506.0% |
| 2006 | -$6M | -246.8% | -$5M | $-4369.24 | -13233.8% | -10259.4% |
| 2005 | -$2M | +0.2% | -$2M | $-3712.85 | -4948.8% | -4540.0% |
| 2004 | -$2M | -67.4% | -$1M | $-6404.29 | -3600.4% | -3036.0% |
| 2003 | -$1M | +10.0% | $-894,329 | $-6239.02 | -1615.5% | -1383.7% |
| 2002 | -$1M | +42.9% | -$1M | $-8104.17 | -1425.8% | -1412.8% |
| 2001 | -$2M | -0.3% | -$2M | $-14058.88 | -1892.1% | -1494.7% |
| 2000 | -$2M | -82.2% | -$3M | $-14022.81 | -381.2% | -473.3% |
| 1999 | -$1M | -234.0% | -$1M | $-14090.46 | -8653.6% | -7955.6% |
| 1997 | $-333,000 | -119.5% | $-252,000 | $-20787.75 | - | - |
| 1996 | $2M | +150.8% | $-257,000 | $106943.00 | - | - |
| 1995 | -$3M | - | -$4M | $-13983.40 | -16.0% | -18.6% |
| 1994 | $0 | - | $210,000 | $0.00 | 0.0% | 2.8% |
Download Data
Export LSTA earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
32+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
LSTA — Frequently Asked Questions
Quick answers to the most common questions about buying LSTA stock.
What is LSTA earnings per share (EPS)?
LSTA trailing twelve-month (TTM) diluted EPS is $-1.82, reflecting +20.4% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1994 to 2025 is available in the table on this page.
What is Lisata Therapeutics, Inc.'s net income?
Lisata Therapeutics, Inc. (LSTA) trailing twelve-month net income is $-16M as of 2025. Earnings grew +20.4% year-over-year.
Is LSTA profitable?
LSTA is not currently profitable on a TTM basis, reporting a net loss of $-16M. Net margin is -9756.5%. Investors should monitor for a return to profitability.
What is LSTA's earnings growth rate?
LSTA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1994 to 2025.
What are LSTA's profit margins?
Lisata Therapeutics, Inc. net profit margin is -9756.5%, operating margin is -10711.2%, and gross margin is +14.1%. Below-average margins reflect competitive or cost pressures. Return on Equity is -75.5%.
Is LSTA growing earnings?
Yes, LSTA earnings are accelerating — EPS growth of +20.4% exceeds the 5-year CAGR of N/A. TTM net income reached $-16M. Earnings momentum is strengthening.
What was LSTA's best earnings year?
Lisata Therapeutics, Inc.'s highest annual net income on record is $23M, achieved in fiscal year 2017. Earnings history on this page spans 1994 to 2025 and includes all annual and quarterly figures.
What were LSTA's earnings last quarter?
LSTA's most recent reported quarter was Q1 2026. Net income was $-4M with diluted EPS of $-0.50. For a full breakdown of all quarters, see the quarterly earnings table on this page.